Physician profile
Bryan Benn
NPI 1144545930
$96,028.32
in general payments reported to CMS, 2019-2025
14 companies · $2,287 in 2025
The $2,287 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,320 · 2021: $10K · 2022: $27K · 2023: $34K · 2024: $9,758 · 2025: $2,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $6,030 · Consulting Fee: $2,138 · Food and Beverage: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,166.25 |
| Travel and Lodging | $6,029.50 |
| Consulting Fee | $2,137.50 |
| Food and Beverage | $1,509.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $76,525.18 | 2021-2025 | Illumisite, Signia |
| Intuitive Surgical, INC. | $10,599.95 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $5,978.65 | 2019-2020 | |
| Erbe USA INC | $1,000.00 | 2021 | |
| Pulmonx Corporation | $565.59 | 2019-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Pinnacle Biologics, INC | $500.00 | 2019-2023 | Photofrin |
| US Endoscopy | $450.00 | 2022 | |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Noah Medical Corporation | $121.84 | 2024 | Galaxy |
| Ethicon INC. | $63.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $31.43 | 2023 | Opsumit |
| Averitas Pharma INC. | $25.81 | 2023 | Qutenza |
| Genzyme Corporation | $22.69 | 2025 | |
| Nalu Medical, INC. | $18.75 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Benn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.